How doping became a topic again at the Tour de France
Translated from German, summarized and contextualized by DistantNews.
At a glance
- Doping has resurfaced as a significant issue at the Tour de France, with around 600 tests planned for the 184 participants.
- The article addresses questions surrounding Jonas Vingegaard's crash, doping tests, biological passports, and potential consequences.
- It highlights that testing can occur at unusual hours under specific conditions, contributing to the heightened scrutiny.
Doping has once again become a prominent topic of discussion surrounding the Tour de France, with extensive testing measures in place. The International Testing Agency plans to conduct approximately 600 tests on the 184 cyclists participating in the event.
The resurgence of doping concerns prompts several key questions: the circumstances of Jonas Vingegaard's crash, the procedures and implications of doping tests, the role of biological passports in monitoring athletes, and the potential repercussions for any violations.
Under specific regulations, doping controls can be administered at unconventional times, adding another layer to the rigorous anti-doping efforts during the race. This heightened level of scrutiny underscores the ongoing battle against performance-enhancing substances in professional cycling.
Originally published by Der Standard in German. Translated, summarized, and contextualized by our editorial team with added local perspective. Read our editorial standards.